Clinical trial
Study of Decitabine for Treatment of Older Patients With Acute Myeloid Leukemia…
NCT00358644 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00358644 |
|---|---|
| Title | Study of Decitabine for Treatment of Older Patients With Acute Myeloid Leukemia (AML) |
| Official title | A Phase II Study of Decitabine For the Front-line Treatment of Older Patients With Acute Myeloid Leukemia |
| Lead sponsor | Eisai Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Myeloid Leukemia |
| Intervention type | Drug |
| Interventions | Decitabine |
| Enrollment | 55 |
| Start date | Mar 1, 2005 |
| Primary completion | Feb 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Aug 1, 2006 |
| Last update posted | May 20, 2013 |
| Countries | United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: